John Wikstrand
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Blood Pressure and Hypertension Studies 73
- Heart Failure Treatment and Management 70
- Cardiovascular Health and Disease Prevention 49
- Cardiovascular Function and Risk Factors 24
- Renin-Angiotensin System Studies 12
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 19
- Co-authors
- Inger Wendelhag (22 shared papers)Björn Fagerberg (52 shared papers)Hans Wedel (36 shared papers)JOHN K. KJEKSHUS (41 shared papers)Olov Wiklund (12 shared papers)Johannes Hulthe (22 shared papers)G Berglund (34 shared papers)Tomas Gustavsson (4 shared papers)
- Journals
- Journal of Internal Medicine (16 papers)Journal of Hypertension (16 papers)European Journal of Heart Failure (14 papers)Hypertension (12 papers)Journal of the American College of Cardiology (9 papers)
- Partner nations
- SwedenUnited KingdomNorway
In The Last Decade
John Wikstrand
252 papers receiving 15.1k citations
John Wikstrand's Hit Papers
Peers
Comparison fields: 5 of 148
- Cardiology and Cardiovascular Medicine 10.1k
- Endocrinology, Diabetes and Metabolism 1.2k
- Surgery 2.6k
- Nephrology 556
- Internal Medicine 120
Countries citing papers authored by John Wikstrand
This map shows the geographic impact of John Wikstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wikstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wikstrand more than expected).
Fields of papers citing papers by John Wikstrand
This network shows the impact of papers produced by John Wikstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wikstrand. The network helps show where John Wikstrand may publish in the future.
Co-authors
The 25 scholars most cited alongside John Wikstrand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 255 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rosuvastatin in Older Patients with Systolic Heart Failure Hit paper breakdown → | 2007 | 1222 |
| 2 | Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure Hit paper breakdown → | 2000 | 1088 |
| 3 | Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials Hit paper breakdown → | 2019 | 607 |
| 4 | Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials Hit paper breakdown → | 2017 | 512 |
| 5 | Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system Hit paper breakdown → | 1991 | 436 |
| 6 | Declining Risk of Sudden Death in Heart Failure Hit paper breakdown → | 2017 | 395 |
| 7 | 1997 | 333 | |
| 8 | 1999 | 324 | |
| 9 | 1988 | 312 | |
| 10 | 2001 | 271 | |
| 11 | 2000 | 257 | |
| 12 | 2002 | 233 | |
| 13 | 2000 | 215 | |
| 14 | 1993 | 207 | |
| 15 | 2000 | 207 | |
| 16 | 2017 | 207 | |
| 17 | 2002 | 194 | |
| 18 | 1992 | 192 | |
| 19 | Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials Hit paper breakdown → | 2022 | 182 |
| 20 | 1992 | 180 |
About John Wikstrand
John Wikstrand is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Pulmonary and Respiratory Medicine and Immunology, having authored 255 papers that have together received 16.4k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (73 papers), Heart Failure Treatment and Management (70 papers), Cardiovascular Health and Disease Prevention (49 papers), Lipoproteins and Cardiovascular Health (28 papers), Cardiovascular Function and Risk Factors (24 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (19 papers), Renin-Angiotensin System Studies (12 papers) and Cerebrovascular and Carotid Artery Diseases (10 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (10.1k citations), Endocrinology, Diabetes and Metabolism (1.2k citations), Surgery (2.6k citations), Nephrology (556 citations) and Internal Medicine (120 citations). John Wikstrand has collaborated with scholars based in Sweden, United Kingdom and Norway. Frequent co-authors include Inger Wendelhag, Björn Fagerberg, Hans Wedel, JOHN K. KJEKSHUS, Olov Wiklund, Johannes Hulthe, G Berglund, Tomas Gustavsson, John J.V. McMurray and Stefan Agewall. Their work appears in journals such as Journal of Internal Medicine, Journal of Hypertension, European Journal of Heart Failure, Hypertension and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.